Hematology/Oncology · West Hollywood, CA
NPI
1396765996
Since 2006
Specialty
Hematology/Oncology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
8737 Beverly Blvd, Suite # 203
West Hollywood, CA, 90048
Phone (323) 525-1111
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.9M
277,975 services
Medicare patients, 2024
413
Average age 76
Drug cost, 2024
$4.0M
3,361 prescriptions
Company payments, 2025
$119
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Levon Qasabian was code J1756 (injection, iron sucrose, 1 mg), 58,600 times for 58 patients. In total Levon Qasabian billed 277,975 services in 195 codes, and Medicare paid $1.9M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-05-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1756 Injection, iron sucrose, 1 mg | Office | 58,600 | 58 | $0.17 | $10K |
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 30,000 | 18 | $0.87 | $26K |
| Q5101 Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram | Office | 24,300 | 12 | $0.14 | $3,404 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 17,400 | 12 | $29.32 | $510K |
| Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 10,720 | 31 | $5.59 | $60K |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 4,880 | 19 | $1.53 | $7,450 |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 4,693 | 37 | $0.07 | $345 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 3,677 | 38 | $0.09 | $330 |
| 85025 Blood Count | Office | 3,132 | 380 | $7.60 | $24K |
| 36415 Venipuncture Blood Collection | Office | 3,095 | 375 | $8.65 | $27K |
| J3475 Injection, magnesium sulfate, per 500 mg | Office | 3,082 | 39 | $0.44 | $1,360 |
| 96361 Intravenous Infusion, Hydration | Office | 2,684 | 110 | $10.91 | $29K |
| 83735 Clinical Chemistry | Office | 2,652 | 351 | $6.56 | $17K |
| J3480 Injection, potassium chloride, per 2 meq | Office | 2,354 | 20 | $0.09 | $202 |
| 80053 Clinical Chemistry | Office | 2,114 | 376 | $10.34 | $22K |
By year: 2022 $1.3M for 229,548 services; 2023 $1.2M for 254,979 services; 2024 $1.9M for 277,975 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 3,132 | 380 | $7.60 | $24K |
| 36415 Venipuncture Blood Collection | 3,095 | 375 | $8.65 | $27K |
| 83735 Clinical Chemistry | 2,652 | 351 | $6.56 | $17K |
| 80053 Clinical Chemistry | 2,114 | 376 | $10.34 | $22K |
| 85046 Blood Count | 1,261 | 229 | $5.46 | $6,880 |
| 83615 Clinical Chemistry | 1,037 | 294 | $5.91 | $6,133 |
| 80048 Clinical Chemistry | 968 | 145 | $8.28 | $8,016 |
| 86141 Clinical Chemistry | 910 | 299 | $12.69 | $12K |
| 85651 Clinical Chemistry | 898 | 303 | $4.18 | $3,754 |
| 83550 Clinical Chemistry | 871 | 210 | $8.57 | $7,464 |
Medicare prescription drug claims, 2024
In 2024, the drug Levon Qasabian prescribed most often to Medicare patients was Gabapentin, with 102 prescriptions and refills. In total Levon Qasabian wrote 3,361 Medicare prescriptions that cost $4.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 102 | 115 | 16 | $751 |
| Rosuvastatin Calcium Generic | 83 | 119 | 14 | $408 |
| Procrit Epoetin Alfa | 75 | 75 | 13 | $115K |
| Metformin Hcl Generic | 73 | 102 | 12 | $149 |
| Zolpidem Tartrate Generic | 65 | 67 | 14 | $242 |
| Lorazepam Generic | 62 | 62 | 20 | $565 |
| Amlodipine Besylate Generic | 60 | 116 | 16 | $278 |
| Atorvastatin Calcium Generic | 59 | 75 | Under 11 | $165 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 58 | 58 | 20 | $879 |
| Ozempic Semaglutide | 57 | 68 | Under 11 | $56K |
| Escitalopram Oxalate Generic | 54 | 74 | Under 11 | $329 |
| Hydroxyurea Generic | 52 | 65 | Under 11 | $783 |
| Dexlansoprazole Dr Dexlansoprazole | 50 | 50 | Under 11 | $7,962 |
| Ondansetron Hcl Generic | 50 | 50 | 20 | $507 |
| Levothyroxine Sodium Generic | 50 | 78 | 11 | $264 |
Brand drugs: 832 claims; generic drugs: 2,506 claims; opioid claims: 152.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Levon Qasabian $119 ($119 in general payments such as food, travel and fees) from 4 companies. The largest payer was Tempus AI, Inc with $53.26.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.